The Patent Finder
AB

Arbor Biotechnologies, Inc.

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

27 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Mar 2038. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2038
Next term end
14
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 6, 2026
    The maintenance fee for Novel CRISPR-Associated Systems and Components (US 11,667,904) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
  • 1 fee due Feb 27, 2027
    The maintenance fee for Novel CRISPR RNA Targeting Enzymes and Systems and Uses Thereof (US 10,392,616) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Novel CRISPR DNA Targeting Enzymes and Systems (US 11,795,442) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 1 fee due May 21, 2027
    The maintenance fee for Gene Editing Systems Comprising an RNA Guide Targeting Hydroxyacid Oxidase 1 (HAO1) and Uses Thereof (US 11,821,012) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
  • 1 fee due Jul 9, 2027
    The maintenance fee for Compositions Comprising a Variant CAS12I4 Polypeptide and Uses Thereof (US 11,866,746) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Novel CRISPR DNA Targeting Enzymes and Systems (US 11,912,992) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 1 fee due Sep 26, 2027
    The maintenance fee for Gene Editing Systems Comprising an RNA Guide Targeting Lactate Dehydrogenase a (LDHA) and Uses Thereof (US 11,939,607) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
  • 1 fee due Oct 2, 2027
    The maintenance fee for Compositions Comprising a Variant Polypeptide and Uses Thereof (US 11,946,045) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
  • 1 fee due Nov 7, 2027
    The maintenance fee for Novel CRISPR DNA Targeting Enzymes and Systems (US 11,976,308) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

What they patent

The 5 largest of its 14 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 10,392,616Novel CRISPR RNA Targeting Enzymes and Systems and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,447,771Novel CRISPR DNA Targeting Enzymes and Systems
In force
 · High confidence
In forceHigh confidence
US 11,643,654Novel CRISPR DNA Targeting Enzymes and Systems
In force
 · High confidence
In forceHigh confidence
US 12,553,045Novel CRISPR DNA Targeting Enzymes and Systems
In force
 · High confidence
In forceHigh confidence
US 10,808,245Novel CRISPR DNA Targeting Enzymes and Systems
In force
 · Medium confidence
In forceMedium confidence
US 11,168,324Novel CRISPR DNA Targeting Enzymes and Systems
In force
 · Low confidence
In forceLow confidence
US 11,912,992Novel CRISPR DNA Targeting Enzymes and Systems
In force
 · Low confidence
In forceLow confidence
US 11,168,322Novel CRISPR RNA Targeting Enzymes and Systems and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,667,904Novel CRISPR-Associated Systems and Components
In force
 · Medium confidence
In forceMedium confidence
US 12,716,060Novel CRISPR-Associated Systems and Components
In force
 · Low confidence
In forceLow confidence
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
Also on record, not counted in the 27: 45 applications pending · 17 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited